loading page

Approaches Towards Fighting COVID-19 in Taiwan
  • +10
  • Shih-Chang Tsai,
  • Chi-Cheng Lu,
  • Da-Tian Bau,
  • Yu-Jen Chiu,
  • Yu-Ting Yen,
  • Yuan‑Man Hsu,
  • Chih-Wei Fu,
  • Sheng-Chu Kuo,
  • Yu-Shiang Lo,
  • Hong‑Yi Chiu,
  • Yu‑Ning Juan,
  • Fuu-Jen Tsai,
  • Jai-Sing Yang
Shih-Chang Tsai
China Medical University
Author Profile
Chi-Cheng Lu
National Taiwan University of Sport
Author Profile
Da-Tian Bau
China Medical University Hospital
Author Profile
Yu-Jen Chiu
Taipei Veterans General Hospital
Author Profile
Yu-Ting Yen
China Medical University
Author Profile
Yuan‑Man Hsu
China Medical University
Author Profile
Chih-Wei Fu
Industrial Technology Research Institute
Author Profile
Sheng-Chu Kuo
China Medical University
Author Profile
Yu-Shiang Lo
China Medical University Hospital
Author Profile
Hong‑Yi Chiu
Buddhist Tzu Chi General Hospital
Author Profile
Yu‑Ning Juan
China Medical University Hospital
Author Profile
Fuu-Jen Tsai
China Medical University
Author Profile
Jai-Sing Yang
China Medical University Hospital
Author Profile

Abstract

The coronavirus disease 2019 (COVID-19) outbreak, which has caused millions of confirmed infections and thousands of deaths, has been the most devastating worldwide crises recently. The main clinical symptoms of confirmed COVID-19 cases include fever, dry cough, general fatigue, respiratory symptoms, diarrhoea and sore throat, similar to those of acute respiratory distress syndrome. SARS-CoV-2, the causative agent of COVID-19, belongs to a novel coronavirus strain against which no drug or vaccine currently exists. Therefore, research units around the world have been actively developing efficient diagnostic tools and new drugs. This review summarises the clinical manifestations of COVID-19, analyses the viral genome sequence and life cycle, identifies methods for preventing viral transmission, discusses possible molecular pharmacologic mechanisms and approaches in the development of anti-SARS-CoV-2 virus therapeutic agents and introduces management measures against COVID-19 in Taiwan, especially policies for a name-based mask distribution system. Finally, we summarise traditional Chinese medicines (TCM) for COVID-19. Based on all the information accumulated in this review, development of novel anti-viral agents, vaccines for SARS-CoV-2 therapy or an effective combination therapy can be expected. Finally, we would like to extend our best regards to the frontline health workers in their global fight against COVID-19.